CSS
TMDX icon

Cubist Systematic Strategies’s Transmedics TMDX Stock Holding History

Cubist Systematic Strategies’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-164,065
Closed -$11.3M – 3531
2024
Q4 		$10.2M Buy
+164,065
New +$15.3M 0.06% 456
2024
Q2 		– Sell
-3,417
Closed -$410K – 4006
2024
Q1 		$253K Sell
3,417
-22,781
-87% -$1.88M ﹤0.01% 2969
2023
Q4 		$2.07M Sell
26,198
-24,088
-48% -$1.45M 0.01% 1483
2023
Q3 		$2.75M Sell
50,286
-9,225
-16% -$664K 0.02% 1141
2023
Q2 		$5M Buy
59,511
+1,281
+2% +$98.1K 0.03% 850
2023
Q1 		$4.41M Buy
58,230
+19,836
+52% +$1.37M 0.03% 1040
2022
Q4 		$2.37M Sell
38,394
-33,366
-46% -$1.77M 0.01% 1702
2022
Q3 		$3M Buy
71,760
+52,226
+267% +$2.27M 0.02% 1594
2022
Q2 		$614K Buy
+19,534
New +$521K ﹤0.01% 2892
2021
Q3 		– Sell
-677
Closed -$22K – 3177
2021
Q2 		$22K Sell
677
-2,670
-80% -$74K ﹤0.01% 2841
2021
Q1 		$139K Buy
3,347
+3,233
+2,836% +$99.5K ﹤0.01% 2580
2020
Q4 		$2K Sell
114
-2,059
-95% -$30.5K ﹤0.01% 2530
2020
Q3 		$30K Buy
+2,173
New +$37.2K ﹤0.01% 2400
2019
Q3 		– Sell
-10,848
Closed -$314K – 2481
2019
Q2 		$314K Buy
+10,848
New +$296K 0.01% 1769

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cubist Systematic Strategies's TMDX Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Transmedics (TMDX) in Q1 2025, closing a stake of 164,065 shares — an estimated $11.3M sold.

Cubist Systematic Strategies first reported a position in TMDX in Q2 2019 and held it in 14 quarters. The position peaked at $10.2M in Q4 2024. 298 funds tracked by Wall St. Rank hold TMDX as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Transmedics position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 164,065 Transmedics shares in Q1 2025, an estimated $11.3M.
  • Cubist Systematic Strategies first reported a position in Transmedics in Q2 2019 and held it in 14 quarters.
  • Cubist Systematic Strategies's Transmedics position peaked at $10.2M in Q4 2024.
  • 298 funds tracked by Wall St. Rank held Transmedics as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.